Literature DB >> 20605468

A 22-year-old Australian woman with atypical subacute sclerosing panencephalitis diagnosed at postmortem.

Victoria A Fabian1, Hwei-Yee Lee, Julia Lee Keith-Rokosh, Jean-Louis de Souza, Edward Stewart-Wynne.   

Abstract

Measles remains a significant global health problem. Despite the decline in measles prevalence in Australia following the implementation of a national vaccination program, challenges surrounding this disease remain. This report describes a 22-year-old woman who presented with coordination loss, tremor, choreiform movements and marked visual blurring, and her condition rapidly deteriorated to coma and death. Antemortem investigations did not yield a unifying diagnosis. Postmortem examination provided a diagnosis of subacute sclerosing panencephalitis. This patient had a rare neurological complication of measles infection, and her condition is remarkable for the atypical clinical presentation. Copyright 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20605468     DOI: 10.1016/j.jocn.2009.12.016

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  3 in total

1.  Adult-onset subacute sclerosing panencephalitis manifesting as slowly progressive dementia.

Authors:  Adalberto Studart Neto; Paulo Ribeiro Nóbrega; Maria Irma Seixas Duarte; Leandro Tavares Lucato; Luiz Henrique Martins Castro; Ricardo Nitrini
Journal:  J Neurovirol       Date:  2015-04-08       Impact factor: 2.643

Review 2.  Relevance of the Measles Virus Expression in Cancer - an Update.

Authors:  Daniel Benharroch; Samuel Ariad; Noa Tadmor; Karen Nalbandyan; Irena Lazarev
Journal:  Pathol Oncol Res       Date:  2016-06-10       Impact factor: 3.201

3.  Basal ganglia lesions in subacute sclerosing panencephalitis.

Authors:  Kelson James Almeida; Sonia Maria Dozzi Brucki; Maria Irma Seixas Duarte; Carlos Augusto Gonçalves Pasqualucci; Sérgio Rosemberg; Ricardo Nitrini
Journal:  Dement Neuropsychol       Date:  2012 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.